Szymanska Edyta, Sredzinska Malgorzata, Ciara Elzbieta, Piekutowska-Abramczuk Dorota, Ploski Rafal, Rokicki Dariusz, Tylki-Szymanska Anna
Department of Pediatrics, Nutrition and Metabolic Disorders, The Children's Memorial Health Institute, Warsaw, Poland.
Department of Medical Genetics, The Children's Memorial Health Institute, Warsaw, Poland.
Mol Genet Metab Rep. 2015 Oct 22;5:48-50. doi: 10.1016/j.ymgmr.2015.10.004. eCollection 2015 Dec.
Tyrosinemia type 3 (HT3) is a rare inborn error of tyrosine metabolism caused by mutations in the gene encoding 4-hydroxyphenyl-pyruvate dioxygenase, which is transmitted in an autosomal recessive trait. The disorder is characterized by tyrosine accumulation in body fluids and massive excretion of tyrosine derivatives into urine (www.orpha.net). Since it is the least frequent form of tyrosinemia, only few cases with the variable but rather mild clinical features have been described so far. We report an 11 year old girl presenting with no clinical symptoms and with normal mental development who has been diagnosed with HT3 through metabolic screening on the basis of elevated serum level of tyrosine ranging from 425 to 535 μmol/L (normal values: 29-86 μmol/L), and elevated urinary excretion of p-hydroxyphenyl derivatives confirmed genetically with the homozygous c.479A > G (p.Tyr160Cys) missense change in the gene. The girl has been only presenting with recurrent proteinuria of unknown etiology. A phenylalanine- and tyrosine-restricted diet has never been administered. Presented case may suggest that high tyrosine concentration itself does not participate directly in neuronal damage described in patients with tyrosinemia type 3.
3型酪氨酸血症(HT3)是一种罕见的酪氨酸代谢先天性缺陷病,由编码4-羟基苯丙酮酸双加氧酶的基因突变引起,呈常染色体隐性遗传。该病症的特征是体液中酪氨酸蓄积以及酪氨酸衍生物大量排泄到尿液中(www.orpha.net)。由于它是酪氨酸血症最不常见的形式,迄今为止仅报道了少数具有不同但相对较轻临床特征的病例。我们报告了一名11岁女孩,无临床症状,智力发育正常,通过代谢筛查被诊断为HT3,其血清酪氨酸水平升高至425至535μmol/L(正常值:29 - 86μmol/L),尿中对羟基苯衍生物排泄增加,经基因检测证实该基因存在纯合的c.479A > G(p.Tyr160Cys)错义突变。该女孩仅表现为病因不明的复发性蛋白尿。从未给予过苯丙氨酸和酪氨酸限制饮食。该病例提示,高酪氨酸浓度本身可能并不直接参与3型酪氨酸血症患者所描述的神经元损伤。